Trials / Completed
CompletedNCT03637348
Effect of TrueTear Corneal Surface Imaging
Effect of TrueTear Use on Anterior Corneal Surface Imaging Quality
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Price Vision Group · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the utility of TrueTear™ to improve anterior corneal surface imaging quality before cataract surgery, refractive lens exchange, or laser refractive surgery.
Detailed description
Corneal imaging will be repeated before and after TrueTear use during a single patient visit. Image quality measures will be compared.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TrueTear | Ues of TrueTear neurostimulator |
Timeline
- Start date
- 2018-08-13
- Primary completion
- 2019-07-08
- Completion
- 2019-07-08
- First posted
- 2018-08-20
- Last updated
- 2020-08-11
- Results posted
- 2020-08-03
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03637348. Inclusion in this directory is not an endorsement.